Related Experiment Videos
Do thyroid-stimulating immunoglobulins cause non-toxic and toxic multinodular goitre?
Lancet (London, England)
|April 29, 1978
Summary
Serum thyroid-stimulating immunoglobulins (T.S.I.) are elevated in Graves' disease, Hashimoto's thyroiditis, and multinodular goiter. These findings suggest T.S.I. may play a role in non-toxic multinodular goiter development.
Area of Science:
- Endocrinology
- Immunology
Background:
- Thyroid-stimulating immunoglobulins (T.S.I.) are antibodies that can stimulate the thyroid gland.
- Their role in various thyroid diseases requires further elucidation.
Purpose of the Study:
- To determine the prevalence of serum T.S.I. in different thyroid conditions.
- To investigate the potential association between T.S.I. levels and specific thyroid pathologies.
Main Methods:
- Measurement of serum T.S.I. levels in 96 patients with various thyroid diseases and 35 healthy controls.
- Comparison of T.S.I. levels across different patient groups and the control group.
Main Results:
- Significantly elevated T.S.I. levels were observed in Graves' disease, Hashimoto's thyroiditis, and both non-toxic and toxic multinodular goiter.
- T.S.I. levels did not differ from controls in patients with single autonomously functioning thyroid nodules, subacute thyroiditis, or "hyperthyroiditis".
Conclusions:
- Elevated T.S.I. is present in a broader range of thyroid diseases than previously recognized, including multinodular goiter.
- Increased circulating T.S.I. is postulated as a potential cause for non-toxic multinodular goiter and may lead to thyrotoxicosis in some cases.